Compartir
Título
In-tube solid phase microextraction coupled to miniaturized liquid chromatography for both, noble metal nanoparticle assessment and sensitive plasmonic assay development
Autor(es)
Palabras clave
Plasmonic assay
Miniaturized liquid chromatography
In-tube SPME
Acids
Spermine
Urine sample
Noble nanoparticle assessment
Clasificación UNESCO
2301 Química Analítica
Fecha de publicación
2021-08-01
Editor
Elsevier
Citación
Sanjuan-Navarro, L.; Cortés-Bautista, S.; Moliner-Martínez, Y.; Campíns-Falcó, P. (2021). In-tube solid phase microextraction coupled to miniaturized liquid chromatography for both, noble metal nanoparticle assessment and sensitive plasmonic assay development. Analytica Chimica Acta, 1171, 338665.
Resumen
[EN]Colorimetric localized surface plasmon resonance (LSPR) as analytical response is applied for a wide number of chemical sensors and biosensors. However, the dependence of different factors, such as size distribution of nanoparticles (NPs), shape, dielectric environment, inter-particle distance and matrix, among others, can provide non-reliable results by UVevis spectrometry in complex matrices if NP assessment is not carried out, particularly at low levels of analyte concentrations. Miniaturized liquid chromatography, capillary (CapLC) and nano (NanoLC), coupled on line with in-tube solid phase microextraction (IT-SPME) is proposed for the first time for both, controlling suitability of used noble metal NP dispersions and developing plasmonic assays. Several capped noble NPs and target analytes were tested fromvariations in the chromatographic profiles obtained by using diode array detection. The IT-SPME step, which influenced the chromatographic fingerprint provided by noble NP dispersions, was studied by asymmetrical flow field flow fractionation (AF4) too. We monitored NP aggregation induced by interaction with several analytes like acids and spermine (SPN). Assessment of NPs was achieved in less than 10 min and it permitted to develop suitable plasmonic tests. Here, it was also demonstrated that these assays can be followed by IT-SPME-miniaturized LC-DAD and more sensitivity and selectivity than those provided by UVeVis spectrometry were achieved. Analysing urine samples to determine SPN as a cancer biomarker as a proof of concept is presented.
URI
ISSN
0003-2670
DOI
10.1016/j.aca.2021.338665
Versión del editor
Aparece en las colecciones
- DQANB. Artículos [108]
Ficheros en el ítem
Tamaño:
1.805Mb
Formato:
Adobe PDF
Descripción:
Versión aceptada del artículo












